Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease
Hager Mohamed, Gaurav Nayak, Nicole Rendine, Brian Wigdahl, Fred C. Krebs, Peter J. Bruggeman, Vandana Miller and Univ. of Minnesota, Minneapolis, MN (United States)
Pathogenic viruses cause many human, animal, and plant diseases that are associated with substantial morbidity, mortality and socio-economic impact. Although effective strategies for combatting virus transmission and associated disease are available, global outbreaks of viral pathogens such as the virus responsible for the COVID-19 pandemic demonstrate that there is still a critical need for new approaches that can be used to interrupt the chain of viral infection and mitigate virus-associated pathogenesis. Recent studies point to non-thermal plasma (NTP), a partly ionized gas comprised of a complex mixture of reactive oxygen and nitrogen species along with physical effectors, as the potential foundation for new antiviral approaches. A more thorough understanding of the antiviral properties and safety of NTP has stimulated explorations of NTP as the basis for treatments of viral diseases. The recently described immunomodulatory properties of NTP are also being evaluated for potential use in immunotherapies of viral diseases as well as in antiviral vaccination strategies. In this review, we present the current state-of-the-art in addition to compelling arguments that NTP merits further exploration for use in the prevention and management of viral infections and associated diseases.
Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease
Creators
Hager Mohamed - Drexel University
Gaurav Nayak - Univ Minnesota, Dept Mech Engn, Coll Sci & Engn, 111 Church St SE, Minneapolis, MN 55455 USA
Nicole Rendine - Drexel University
Brian Wigdahl - Drexel University
Fred C. Krebs - Drexel University
Peter J. Bruggeman - Univ Minnesota, Dept Mech Engn, Coll Sci & Engn, 111 Church St SE, Minneapolis, MN 55455 USA
Vandana Miller - Drexel University
Univ. of Minnesota, Minneapolis, MN (United States)
Publication Details
Frontiers in physics, v 9
Publisher
Frontiers Media Sa
Number of pages
25
Grant note
Coulter Foundation
DE-SC0016053 / Department of Energy, Office of Fusion Energy Science; United States Department of Energy (DOE)
PHY 2020695 / National Science Foundation; National Science Foundation (NSF)
Institute for Molecular Medicine and Infectious Disease at the Drexel University College of Medicine
Department of Microbiology and Immunology at the Drexel University College of Medicine
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology
Web of Science ID
WOS:000661540000001
Scopus ID
2-s2.0-85107969313
Other Identifier
991019168303804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: